TomTec Imaging Systems introduces 4D MV- Assessment software for Mitral Valve measurement

NewsGuard 100/100 Score

TomTec Imaging Systems GmbH today announced the introduction of its new 4D MV-Assessment© 2.0 software. The 4D MV- Assessment software combines the strength of 2D with the advantages of 3D echocardiography to provide the doctor with important and partly unprecedented diagnostic information and measurements for the Mitral Valve.

The trend to operate even asymptomatic patients suffering from mitral regurgitation becomes more and more important. Using 3D echocardiographic datasets, 4D MV- Assessment presents the anatomical structures of the Mitral Valve, annulus and the closure line of the two leaflets in a three dimensional model which for the first time can be analyzed dynamically. In addition to that, comprehensive measurements enable doctors to quantify pathological findings. Thus 4D MV-Assessment provides precise diagnostic information about valve morphology that would be hard to obtain with conventional echocardiography. Automated features and a completely revised workflow have considerably shortened examination times and deliver quantitative parameters for the doctor's decision making in 20 seconds.

"Current 4D Mitral Valve assessment tools have shown that a static analysis is problematic for reproducibility and communication since the parameters are depending on the chosen heart phase. TomTec`s new 4D MV-Assessment software analyses the whole systolic heart cycle and together with its dramatic improvements in workflow it addresses the needs of cardiologists and surgeons for improved communication and clinical decision making", said Frank Schlau, TomTec`s Chief Marketing Officer.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Deep learning shines a new light on Parkinson's detection through the eye